Head-to-head · WeighScore
Ondra Health vs RENN Health
By GLP-1 ScorecardUpdated
Score comparison
Ondra Health has the higher recorded score — 86.8/100 to 69.3/100.
Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ondra publishes monthly and prepaid compounded injection plans with pharmacy choices; compare the upfront bill, eligible pharmacy and early-cancellation repricing before choosing a term.
Before you choose
Before comparing the headline prices, the Ondra Health review and the RENN Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Ondra Health vs Revive Meds and PepHaūs vs RENN Health compare each of them with another graded program, and the list of alternatives to Ondra Health ranks the programs closest to Ondra Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Peter MD review covers one graded close to these two, at 78.1/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ondra Health | RENN Health |
|---|---|---|
| WeighScore | 86.8/100 | 69.3/100 |
| Grade | B | C |
| Site position | #5 | #143 |
| Semaglutide | $149/mo (compounded; month-to-month) | From $149/mo (the site's own floor; it publishes no billing cycle and no standing rate) |
| Tirzepatide | $219/mo (compounded; month-to-month) | From $199/mo (the site's own floor; it publishes no billing cycle and no standing rate) |
| Coverage | Advertises 50 states; pharmacy and formulation eligibility varies | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes monthly charges and separate upfront totals for longer plans
- Allows requests for an eligible pharmacy and formulation, subject to prescribing and availability
- Names independent clinical partners and advertises provider messaging, supplies and shipping
What to consider
- Six- and twelve-month plans require prepayment and an eligible Hallandale or Vials prescription
- Early prepaid cancellation reprices each three-month supply already sent at the regular quarterly rate
- Confirm the selected renewal cutoff and any earned consultation or administrative fees
- Branded and oral access, included lab testing and independent current certification were not established
Strengths
- Names six dispensing pharmacies with websites and phone numbers — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills
- Names two prescribing physicians with their NPI numbers and the medical group behind them, which almost nothing else at this price does
- Prices a registered dietitian, the telehealth visit and overnight cold shipping at zero rather than adding them later
- Care is stated as available to patients in all 50 U.S. states
What to consider
- No refund, cancellation or auto-renewal terms exist anywhere on the site, on a subscription product sold with three- and six-month prepay bundles
- “As low as $149” and “as low as $199” are floors with no billing cycle attached, and the site never states what the standing monthly rate is or what the floor requires
- The memberships page ships placeholder text — “Membership 1 / short description placeholder” and the word Placeholder where a price belongs — and it is in the site's own sitemap
- The word compounded never appears on the marketing site; the disclosure exists only in an interface the patient does not see
- Semaglutide and tirzepatide tablets are marked visible in the patient's own intake catalog and appear nowhere on the public site
- The Terms carry two governing-law clauses that name different jurisdictions
- Belmar, one of the six named dispensing pharmacies, is the subject of an FDA warning letter issued March 2023 to “Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy”, which the FDA closed out in October 2023. It concerns a supplier; RENN Health carries no warning letter of its own
- No compounding class is stated for any of the six pharmacies
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.